Hessekiel Jeffrey insider trades
Hessekiel Jeffrey has filed 38 Form 4s with the SEC that we hold, for Exelixis, INC. (EXEL) (EVP & General Counsel) and Cytokinetics INC (CYTK) (Chief Legal & Admin Officer). Across all of them we count 0 purchases worth $0 and 20 sales worth $15.9M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 60,000 shares of Exelixis, INC. worth $2.2M, dated 2024-11-29. The first filing on our record is dated 2021-10-04 and the latest 2026-03-17.
Exelixis, INC. (EXEL)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-05-17 | S, sale reported on Form 4 | 18,000 | $457.0K | 2022-11-17 |
| 2021-10-15 | S, sale reported on Form 4 | 12,883 | $283.7K | 2021-10-15 |
| 2021-11-01 | S, sale reported on Form 4 | 5,117 | $112.7K | 2021-11-03 |
| 2022-02-24 | S, sale reported on Form 4 | 18,000 | $360.0K | 2022-02-28 |
| 2022-03-28 | S, sale reported on Form 4 | 4,717 | $103.8K | 2022-03-30 |
| 2022-03-29 | S, sale reported on Form 4 | 13,283 | $292.2K | 2022-03-30 |
| 2022-05-16 | S, sale reported on Form 4 | 18,000 | $361.3K | 2022-11-17 |
| 2023-03-01 | S, sale reported on Form 4 | 77,860 | $1.3M | 2023-03-03 |
| 2023-04-05 | S, sale reported on Form 4 | 38,930 | $779.0K | 2023-04-05 |
| 2023-08-01 | S, sale reported on Form 4 | 55,710 | $1.1M | 2023-08-03 |
| 2023-11-30 | S, sale reported on Form 4 | 25,000 | $550.2K | 2023-12-04 |
| 2023-12-04 | S, sale reported on Form 4 | 25,000 | $551.5K | 2023-12-04 |
| 2023-12-13 | S, sale reported on Form 4 | 25,000 | $575.2K | 2023-12-14 |
| 2024-08-07 | S, sale reported on Form 4 | 80,000 | $2.1M | 2024-08-09 |
| 2024-08-26 | S, sale reported on Form 4 | 20,000 | $515.8K | 2024-08-28 |
| 2024-09-23 | S, sale reported on Form 4 | 25,000 | $659.5K | 2024-09-25 |
| 2024-10-28 | S, sale reported on Form 4 | 25,000 | $709.8K | 2024-10-30 |
| 2024-11-01 | S, sale reported on Form 4 | 50,000 | $1.7M | 2024-11-05 |
| 2024-11-29 | S, sale reported on Form 4 | 60,000 | $2.2M | 2024-12-02 |
| 2025-05-15 | S, sale reported on Form 4 | 25,000 | $1.2M | 2025-05-16 |
Cytokinetics INC (CYTK)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1599803) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms